Table 3.
Per-person lifetime cost-savings and aggregate cost-savings if the Healthy People (HP) 2020 target of reducing invasive colorectal cancer (CRC) by 15% for each group were achieved.a
| Per-person lifetime cost- savingsb (2013$) (SE) | Aggregate lifetime cost-savingsc (million, 2013$) | |
|---|---|---|
| Total | – | 623.5 |
| Sex* | ||
| Male | 24,000 (24) | 329.3 |
| Female | 28,000 (30) | 294.2 |
| Race/ethnicity* | ||
| Non-Hispanic White | 27,000 (23) | 371.1 |
| Non-Hispanic Black | 23,000 (42) | 80.8 |
| Hispanic | 26,000 (47) | 102.5 |
| Age group (years)* | ||
| 50–54 | 46,000 (68) | 79.8 |
| 55–59 | 45,000 (70) | 111.5 |
| 60–64 | 43,000 (68) | 143.9 |
| 65–69 | 32,000 (59) | 142.7 |
| 70–74 | 28,000 (53) | 129.7 |
| 75–79 | 22,000 (53) | 88.9 |
| 80+ | 15,000 (30) | 100.0 |
SE, standard error.
All healthcare costs were adjusted to 2013 dollars using the Personal Health Care Expenditure Price Index. CRC status, age, sex, race, education, marital status, number of comorbid conditions, health insurance, and census region were controlled for in the two-part model.
See Section 2.5 for the calculation of per-person lifetime cost-savings.
Aggregate cost-savings were calculated by multiplying the estimated reduction in the number of CRC patients with per-person lifetime cost-savings.
p < 0.05 comparing statistically significant difference in per-person lifetime cost savings among sex, race/ethnicities and age groups.